Rejuvaskin Mineral Facial Sunscreen SPF 32 Sheer

Manufacturer
Atlantic Medical Products, LLC | Inspec Solutions
Effective date
2026-01-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:34:36

Label at a glance#

ProductRejuvaskin Mineral Facial Sunscreen SPF 32 Sheer
Active ingredientZINC OXIDE
Label structure11 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Zinc Oxide 20%...................Sunscreen

WHEN USING

OTC - WHEN USING SECTION

When using this Product keep out of eyes. Rinse with water to remove.

WARNINGS

WARNINGS SECTION

For external use only.

STOP USE

OTC - STOP USE SECTION

Stop use and ask a physician if rash occurs.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

DO NOT USE

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Inactive Ingredients

Benzyl Alcohol

Butyloctyl Salicylate

Caprylic/Capric Triglyceride

Citric Acid

Coco-Caprylate

Dehydroacetic Acid

Glycerin

Glyceryl Stearate

Niacinamide

Pathenol

Polyhydroxystearic Acid

Sodium Phytate

Saccharide Isomerate

Sodium Stearoyl Glutamate

Sucrose palmitate-stearate

Sucrose Laurate

Tocopheryl Acetate

Water

Xanthan Gum

PURPOSE

OTC - PURPOSE SECTION

Active Ingredients

Zinc Oxide 20%..............................................Sunscreen

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Uses helps prevent sunburn.

If used as directed with other sun protection measures (see Directions) decreases the risk of skin cancer and early aging caused by the sun.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Directions

Apply liberally to face and neck 15 minutes before sun exposure.

Use a water-resistant sunscreen if swimming or sweating.

Reapply at least every two hours.

Sun Protection measures: Spending time in the sun increases your risk of skin cancer and early

skin aging. To decrease this risk, regularly use a sunscreen with broad-spectrum SPF of 15 or

higher and other sun protection measures including

limit time in the sun, especially from 10am - 2pm;

wear long-sleeve shirts, pants, hats, and sunglasses.

Children under 6 months: Ask a physician

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL

Principal Display PanelPrincipal Display Panel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84375-101-02Rejuvaskin Mineral Facial Sunscreen SPF 32 Sheer60 g in 1 TUBELOTION601

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84375-10184375-101-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Rejuvaskin Mineral Facial Sunscreen SPF 32 SheerREJUVASKIN MINERAL FACIAL SUNSCREEN SPF 32 SHEERAtlantic Medical Products , LLC1a2ab632-6443-1aa9-e063-6394a90a0c052026-06-11WarningsExact identifier
ndc (product): 84375-101
Rejuvaskin Mineral Facial Sunscreen SPF 32 SheerREJUVASKIN MINERAL FACIAL SUNSCREEN SPF 32 SHEERAtlantic Medical Products, LLC47e5198e-7bf6-72a8-e063-6294a90a7ec52026-01-08WarningsExact identifier
ndc (package): 84375-101-02
ndc (product): 84375-101
ndc11 (package): 84375010102
spl id: 47e5198e-7bf7-72a8-e063-6294a90a7ec5
spl set id: 47e5198e-7bf6-72a8-e063-6294a90a7ec5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.